The Rise of Pluripotent Stem Cell-Derived Glia Models of Neuroinflammation
Neurology International,
Journal Year:
2025,
Volume and Issue:
17(1), P. 6 - 6
Published: Jan. 13, 2025
Neuroinflammation
is
a
blanket
term
that
describes
the
body’s
complex
inflammatory
response
in
central
nervous
system
(CNS).
It
encompasses
phenotype
shift
to
proinflammatory
state,
release
of
cytokines,
recruitment
peripheral
immune
cells,
and
wide
variety
other
processes.
has
been
implicated
nearly
every
major
CNS
disease
ranging
from
Alzheimer’s
brain
cancer.
Understanding
modeling
neuroinflammation
critical
for
identification
novel
therapeutic
targets
treatment
diseases.
Unfortunately,
translation
findings
non-human
models
left
much
be
desired.
This
review
systematically
discusses
role
human
pluripotent
stem
cell
(hPSC)-derived
glia
supporting
cells
within
CNS,
including
astrocytes,
microglia,
oligodendrocyte
precursor
pericytes,
endothelial
describe
state
field
hope
future
discoveries.
hPSC-derived
offer
an
expanded
potential
study
pathobiology
immunomodulatory
cascades
impact
progression.
While
progress
made
development
models,
there
explore
application
these
understand
CNS.
Language: Английский
A dual role for pleiotrophin in modulating inflammation and myelination in the presence of chondroitin sulfate proteoglycans after nervous system injury
Frontiers in Cellular Neuroscience,
Journal Year:
2025,
Volume and Issue:
19
Published: Feb. 27, 2025
Chondroitin
sulfate
proteoglycans
(CSPGs),
key
components
of
the
extracellular
matrix
and
glial
scar
that
forms
around
central
nervous
system
(CNS)
injuries,
are
recognized
for
hindering
neuronal
regeneration.
We
previously
demonstrated
potential
pleiotrophin
(PTN)
to
induce
neurite
outgrowth
even
in
presence
inhibitory
CSPGs.
The
effects
PTN
on
microglia
oligodendrocytes
not
well
described.
Here,
we
examined
how
administration
alters
differentiation
oligodendrocyte
precursor
cells
(OPCs)
into
mature
CSPGs
using
vitro
cell
culture
model.
Moreover,
explored
inflammatory
activity
with
without
stimulation
(IFN-γ)
a
CSPG-rich
environment.
data
showed
CSPG
inhibited
OPCs
oligodendrocytes.
induced
dose-dependent
oligodendrocytes,
an
optimal
effect
at
10
nM
PTN.
modified
immunological
response
CSPGs,
reduced
proinflammatory
was
further
by
administration,
contrast
increased
release
metalloproteinases
(MMP
9).
However,
when
IFN-γ-activated
were
treated
PTN,
signaling
stimulated
higher
concentrations
(10
100
nM).
Overall,
our
results
indicate
can
overcome
modulate
inflammation
mediated
from
microglia.
Collectively,
these
findings
demonstrate
effectively
counteract
while
also
modulating
microglial
responses
reduce
increase
MMP-9
release.
Thus,
has
great
improve
remyelination
neuroprotective
strategies
treatment
demyelinating
diseases
or
any
injury.
Language: Английский
Insights from Selenoprotein I mouse models for understanding biological roles of this enzyme
Archives of Biochemistry and Biophysics,
Journal Year:
2025,
Volume and Issue:
unknown, P. 110394 - 110394
Published: March 1, 2025
Language: Английский
Alzheimer’s Disease, Obesity, and Type 2 Diabetes: Focus on Common Neuroglial Dysfunctions (Critical Review and New Data on Human Brain and Models)
Brain Sciences,
Journal Year:
2024,
Volume and Issue:
14(11), P. 1101 - 1101
Published: Oct. 30, 2024
Obesity,
type
2
diabetes
(T2D),
and
Alzheimer's
disease
(AD)
are
pathologies
that
affect
millions
of
people
worldwide.
They
have
no
effective
therapy
difficult
to
prevent
control
when
they
develop.
It
has
been
known
for
many
years
these
diseases
pathogenic
aspects
in
common.
We
highlight
this
review
neuroglial
cells
(astroglia,
oligodendroglia,
microglia)
play
a
vital
role
the
origin,
clinical-pathological
development,
course
brain
neurodegeneration.
Moreover,
we
include
new
results
T2D-AD
mouse
model
(APP+PS1
mice
on
high-calorie
diet)
investigating.
Language: Английский
(Re)building the nervous system: A review of neuron–glia interactions from development to disease
Journal of Neurochemistry,
Journal Year:
2024,
Volume and Issue:
169(1)
Published: Dec. 16, 2024
Abstract
Neuron–glia
interactions
are
fundamental
to
the
development
and
function
of
nervous
system.
During
development,
glia,
including
astrocytes,
microglia,
oligodendrocytes,
influence
neuronal
differentiation
migration,
synapse
formation
refinement,
myelination.
In
mature
brain,
glia
crucial
for
maintaining
neural
homeostasis,
modulating
synaptic
activity,
supporting
metabolic
functions.
Neurons,
inherently
vulnerable
various
stressors,
rely
on
protection
repair.
However,
in
their
reactive
state,
can
also
promote
damage,
which
contributes
neurodegenerative
neuropsychiatric
diseases.
Understanding
dual
role
glia—as
both
protectors
potential
aggressors—sheds
light
complex
contributions
disease
etiology
pathology.
By
appropriately
glial
it
may
be
possible
mitigate
neurodegeneration
restore
function.
this
review,
originated
from
International
Society
Neurochemistry
(ISN)
Advanced
School
2019
held
Montreal,
Canada,
we
first
describe
critical
importance
maintenance
a
healthy
system
as
well
damage
neurological
disorders.
We
then
discuss
strategies
modulate
activity
during
protect
properly
functioning
propose
that
targeting
cells
presents
promising
therapeutic
avenue
rebuilding
image
Language: Английский
A new player in the game: identification of C1ql1 as a novel factor driving OPC differentiation
FEBS Journal,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 15, 2024
Oligodendrocytes
(OLGs)
are
the
myelin‐producing
cells
in
central
nervous
system
(CNS).
Following
injury,
these
prone
to
death,
leading
demyelination
and,
eventually,
axonal
loss
and
neurodegeneration.
Upon
damaged
CNS
repopulates
lesion
with
oligodendrocyte
precursor
(OPCs)
that
consequently
mature
into
OLGs
repair
myelin
damage
prevent
further
loss.
In
this
issue,
Altunay
et
al.
identified
complement
component
1,
q
subcomponent‐like‐1
(
C1ql1
),
a
factor
known
play
role
neuron–neuron
synapses,
is
also
expressed
by
OPCs
drives
their
differentiation
OLGs.
These
data
suggest
or
other
downstream
factors
could
be
therapeutic
targets
context
of
demyelinating
disorders
which
remyelination
fails,
such
as
multiple
sclerosis
(MS).
Language: Английский